Managing particulates in cell therapy: Guidance for best practice.
review · Level V
Where this comes from
- Record sourced from PubMed, PMID 27426934.
- Also identified by DOI 10.1016/j.jcyt.2016.05.011.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
The intent of this article is to provide guidance and recommendations to cell therapy product sponsors (including developers and manufacturers) and their suppliers in the cell therapy industry regarding particulate source, testing, monitoring and methods for control. This information is intended to help all parties characterize the processes that generate particulates, understand product impact and provide recommendations to control particulates generated during manufacturing of cell therapy products.
Medical subject headings
- Cell- and Tissue-Based Therapy
- Particulate Matter
- Patient Safety